|
|
|
|
|
EXTD Zoledronic acid |
|
118072-93-8 |
|
is indicated for the prevention of skeletal related events in patients with advanced malignancies involving bone |
|
99% |
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|